Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

A liver disease drug could be repurposed to protect against COVID – new research

By Teresa Brevini, PhD candidate, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge
Fotios Sampaziotis, UKRI Future Leaders Fellow, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge
Share this article
Almost three years into the pandemic, we’re still regularly seeing hundreds of thousands of new COVID cases recorded each day worldwide. In a new study, involving a combination of miniature organ models, donor organs, animals and humans, we’ve shown that a drug used to treat liver disease could be repurposed to protect against COVID-19.

Vaccines are one of the most potent weapons in our pandemic response, but not everyone can benefit from them. COVID…The Conversation


Read complete article

© The Conversation -
Subscribe to Tolerance.ca


Follow us on ...
Facebook Twitter